Biosimilars and Inflammatory Bowel Disease

(4:4)

Biosimilars and Biologics

(38:15)

Biosimilars and the Approval Process

(2:6)

Biologic Drugs and Biosimilars

(7:21)

Dr. Robson Discusses Differences Between Biosimilars and Biologics in Oncology

(49)

Biologics, Biosimilars, and the Two-fold U.S. Approval Framework’s Possible Impact on Prices

(32:37)

Biosimilars and Sandoz

(4:46)

Biocon Q3: Biosimilars, Research Services Aids Growth, Eye On Launches In FY25 | Siddharth Mittal

(12:16)

Biosimilars and Interchangeables - Regulatory Highlights (27of33) Quality – Oct. 16-17, 2019

(14:31)

Biosimilar and Interchangeable Insulins: What Clinicians Need to Know

(11:18)

What is a biosimilar, exactly?

(3:18)

Biosimilars and Oncology Clinical Pathways: Perfect Together

(51:6)

Biosimilars and Me - Pete Mendez

(4:11)

Biosimilars and what’s new in cell and gene therapies

(37:18)

Differences between Biologics, Biosimilars and Generic Medications

(3:57)

Biosimilars and the Issue of Interchangeability

(4:53)

Biosimilars and Rheumatoid Arthritis | Making the switch

(4:21)

What are biosimilars and why are they important?

(3:57)

S7, Ep 1- The Latest News: Drug Imports, Biosimilars, and COVID/Flu/RSV Season

(17:9)